John J. Mccabe serves as Executive at INTERLEUKIN GENETICS INC, where they oversee executive responsibilities. Since joining the company, John J. Mccabe has executed 6 insider transactions totaling $9.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 6, 2019 involved receiving (via award) 12,867 shares valued at $0.
John J. Mccabe currently holds 12,867 shares of INTERLEUKIN GENETICS INC (ILI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John J. Mccabe has been a net seller of ILI stock. They have purchased $0 and sold $9.0K worth of shares.
John J. Mccabe's most recent insider trade was on Dec 6, 2019, when they sold 12,867 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.10 |
| Discretionary |
| Aug 15, 2016 | EBIO | $5.6K | Sale | 1,170 | $4.80 | Discretionary |
| Feb 16, 2016 | EBIO | $405 | Sale | 1,501 | $0.27 | Discretionary |
| Aug 12, 2015 | EBIO | $0 | Award | 10,000 | $N/A | Discretionary |
| Feb 7, 2006 | ILI | $52.0K | Award | 8,000 | $6.50 | Discretionary |